Cosmos Holdings Inc. (COSM)
| Previous Close | 5.80 |
| Open | 5.78 |
| Bid | 5.82 x 1200 |
| Ask | 5.83 x 1100 |
| Day's Range | 5.73 - 6.10 |
| 52 Week Range | 0.07 - 23.84 |
| Volume | |
| Avg. Volume | 58,020,303 |
| Market Cap | 61.828M |
| Beta (5Y Monthly) | 1.56 |
| PE Ratio (TTM) | 97.17 |
| EPS (TTM) | 0.06 |
| Earnings Date | Nov 16, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Cosmos Health Announces Application for Dual Listing on Upstream
Cosmos Health Inc. (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that is has begun the application process to dual list its shares on Upstream, the trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
- ACCESSWIRE
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer
Cosmos Health Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, is pleased to announce the appointment of Nikos Bardakis, who comes with over two decades of international branded pharmaceutical sector experience, as the Chief Operating Officer (COO).
- ACCESSWIRE
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities
Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announces that in response to the data obtained through Shareholder Intelligence Services, it has retained services of Wes Christian of Christian Levine Law Group and Alan Pollack of Warshaw Burstein, LLP (the "Firms"), to help the company develop
